Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase EARLY_PHASE1 1Phase 4 1Phase 2 1

Status

Completed 39Recruiting 11Unknown 10Terminated 5Active not recruiting 3Withdrawn 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 120Neoplasms 75Prostatic Neoplasms 70Lung Neoplasms 36Carcinoma, Non-Small-Cell Lung 33Pancreatic Neoplasms 32Colorectal Neoplasms 32Head and Neck Neoplasms 29Carcinoma, Hepatocellular 24Brain Neoplasms 24Colonic Neoplasms 22Motor Activity 19Carcinoma, Renal Cell 18Pain 16Ovarian Neoplasms 16Neoplasm Metastasis 14Hematologic Neoplasms 14Urinary Bladder Neoplasms 13Rectal Neoplasms 13Lymphoma, Follicular 13Fatigue 13Sarcoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Glioblastoma 12Lymphoma 11Liver Neoplasms 11Glioma 11Squamous Cell Carcinoma of Head and Neck 10Leukemia 10Anxiety Disorders 10

Interventions

Insulin 1Human Growth Hormone 1Growth Hormone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Withdrawn × Insulin Resistance × Clear all
NCT04139694 2020-05-19

Improving Insulin Resistance in Gynecological Cancer Patients

Woman's

Phase NA Withdrawn

Insulin Resistance

NCT00518635 2013-02-20

Low Dose Growth Hormone in Obese PCOS Women

Oregon Health and Science University

Phase NA Withdrawn

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡